| Citrus bergamia essential oil: from basic research to clinical application M Navarra, C Mannucci, M Delbò, G Calapai Frontiers in pharmacology 6, 36, 2015 | 251 | 2015 |
| Passiflora incarnata L.: ethnopharmacology, clinical application, safety and evaluation of clinical trials M Miroddi, G Calapai, M Navarra, PL Minciullo, S Gangemi Journal of ethnopharmacology 150 (3), 791-804, 2013 | 228 | 2013 |
| Anticancer activity of liposomal bergamot essential oil (BEO) on human neuroblastoma cells C Celia, E Trapasso, M Locatelli, M Navarra, CA Ventura, J Wolfram, ... Colloids and Surfaces B: Biointerfaces 112, 548-553, 2013 | 183 | 2013 |
| Oxidative stress in benign prostatic hyperplasia: a systematic review PL Minciullo, A Inferrera, M Navarra, G Calapai, C Magno, S Gangemi Urologia Internationalis 94 (3), 249-254, 2015 | 175 | 2015 |
| gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors MV Catani, MT Corasaniti, M Navarra, G Nistico, A Finazzi‐Agrò, G Melino Journal of neurochemistry 74 (6), 2373-2379, 2000 | 148 | 2000 |
| Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-κB inhibition in THP-1 monocytes R Risitano, M Currò, S Cirmi, N Ferlazzo, P Campiglia, D Caccamo, ... PloS one 9 (9), e107431, 2014 | 133 | 2014 |
| The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease D Impellizzeri, G Bruschetta, R Di Paola, A Ahmad, M Campolo, ... Clinical Nutrition 34 (6), 1146-1154, 2015 | 131 | 2015 |
| Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role? S Cirmi, N Ferlazzo, GE Lombardo, E Ventura-Spagnolo, S Gangemi, ... Molecules 21 (10), 1312, 2016 | 126 | 2016 |
| Montelukast-induced adverse drug reactions: a review of case reports in the literature G Calapai, M Casciaro, M Miroddi, F Calapai, M Navarra, S Gangemi Pharmacology 94 (1-2), 60-70, 2014 | 121 | 2014 |
| Systematic Review of Clinical Trials Assessing Pharmacological Properties of Salvia Species on Memory, Cognitive Impairment and Alzheimer's Disease M Miroddi, M Navarra, MC Quattropani, F Calapai, S Gangemi, G Calapai CNS neuroscience & therapeutics 20 (6), 485-495, 2014 | 120 | 2014 |
| Cranberry and recurrent cystitis: more than marketing? S Micali, G Isgro, G Bianchi, N Miceli, G Calapai, M Navarra Critical reviews in food science and nutrition 54 (8), 1063-1075, 2014 | 120 | 2014 |
| Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA‐induced cell death in vitro MT Corasaniti, J Maiuolo, S Maida, V Fratto, M Navarra, R Russo, ... British journal of pharmacology 151 (4), 518-529, 2007 | 118 | 2007 |
| Clinical Pharmacology of Citrus aurantium and Citrus sinensis for the Treatment of Anxiety C Mannucci, F Calapai, L Cardia, G Inferrera, G D’Arena, M Di Pietro, ... Evidence‐Based Complementary and Alternative Medicine 2018 (1), 3624094, 2018 | 115 | 2018 |
| Neurological aspects of medical use of cannabidiol C Mannucci, M Navarra, F Calapai, EV Spagnolo, FP Busardò, RD Cas, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2017 | 114 | 2017 |
| Antiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitis M Galuppo, S Giacoppo, GR De Nicola, R Iori, M Navarra, GE Lombardo, ... Fitoterapia 95, 160-174, 2014 | 111 | 2014 |
| The Second Life of Citrus Fruit Waste: A Valuable Source of Bioactive Compounds C Russo, A Maugeri, GE Lombardo, L Musumeci, D Barreca, A Rapisarda, ... Molecules 26 (19), 5991, 2021 | 105 | 2021 |
| Cardiovascular toxicity of tyrosine kinase inhibitors used in chronic myeloid leukemia: an analysis of the FDA adverse event reporting system database (FAERS) S Cirmi, A El Abd, L Letinier, M Navarra, F Salvo Cancers 12 (4), 826, 2020 | 103 | 2020 |
| Anticancer Potential of Citrus Juices and Their Extracts: A Systematic Review of Both Preclinical and Clinical Studies S Cirmi, A Maugeri, N Ferlazzo, S Gangemi, G Calapai, U Schumacher, ... Frontiers in Pharmacology 8, 420, 2017 | 103 | 2017 |
| IL‐33/IL‐31 axis: a potential inflammatory pathway E Di Salvo, E Ventura-Spagnolo, M Casciaro, M Navarra, S Gangemi Mediators of inflammation 2018 (1), 3858032, 2018 | 102 | 2018 |
| Cannabinoids, blood–brain barrier, and brain disposition F Calapai, L Cardia, EE Sorbara, M Navarra, S Gangemi, G Calapai, ... Pharmaceutics 12 (3), 265, 2020 | 98 | 2020 |
